IgniteData, a Reading, UK–based clinical trial technology company, has closed its Series A funding round.
Investors
The round was led by FCA Venture Partners, with participation from existing investors SpringTide and Oncology Ventures.
FCA Venture Partners is a venture capital firm specializing in investments in healthcare companies. Founded in 1996, the firm is headquartered in Nashville, Tennessee, and also has an office in Charlotte, North Carolina. It invests in early-stage and growth-stage companies.
IgniteData Use of Funds
The company will utilize the funding to accelerate global expansion, grow its research site network, and enhance its platform capabilities.
About IgniteData
Led by CEO Zach Taft, IgniteData focuses on intelligent automation for transferring data between electronic health records (EHR) and electronic data capture (EDC) systems. Its flagship product, Archer, enables real-time, secure, and automated transfer of complex clinical trial data, improving speed, accuracy, and collaboration between research sites and sponsors. Headquartered in Reading, United Kingdom, IgniteData is on a mission to revolutionize clinical trials through intelligent automation.
Funding Details
Company: IgniteData, Inc.
Raised: Undisclosed
Round: Series A
Funding Date: August 2025
Lead Investor: FCA Venture Partners
Additional Investors: SpringTide, Oncology Ventures
Company Website: https://ignitedata.com/
Software Category: Clinical Trial Data Automation
Source: https://www.prnewswire.com/news-releases/ignitedata-raises-series-a-to-accelerate-global-site-network-expansion-and-clinical-trial-data-automation-302529751.html